القيمة السوقية تغيير تاريخ
Acadia Pharmaceuticals USD 3.8B 724M 2026-03
Agios Pharmaceuticals USD 2.01B 423M 2026-03
Akebia Therapeutics USD 427M 297M 2025-12
Almirall EUR 2.76B 472.53M 2025-12
Alnylam Pharmaceuticals USD 44.15B 8.39B 2026-03
Amarin USD 290M 51M 2025-12
Astellas Pharma JPY 4.56T 770.92B 2026-03
AstraZeneca USD 301.25B 13.1B 2026-03
Charles River Laboratories USD 7.85B 2.17B 2026-03
Coherus Biosciences USD 172M 19M 2025-12
Emergent BioSolutions USD 125M 51M 2023-12
Esperion Therapeutics USD 885M 351M 2025-12
Halozyme Therapeutics USD 7.66B 257M 2026-03
Incyte USD 18.73B 660M 2026-03
Karyopharm Therapeutics USD 1.05B 912M 2026-06
Lexicon Pharmaceuticals USD 418M 73M 2025-12
Moderna USD 20.15B 8.53B 2026-03
Pacira USD 915M 149M 2026-03
PTC Therapeutics USD 5.64B 460M 2026-03
Sarepta Therapeutics USD 2.28B 30M 2026-03
Takeda JPY 9.01T 1.37T 2026-03
Ultragenyx Pharmaceutical USD 2.06B 159M 2026-03
Vanda Pharmaceuticals USD 279M 6M 2024-12